These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 5157256)

  • 21. [Activity of the Center for study of Rh factors of the Clinica Ostetrica e Ginecologica of the University of Naples in the prevention of hemolytic disease of the newborn].
    Paladini A; Di Martino D; De Luca P; Rascio B; Di Lieto A
    Arch Ostet Ginecol; 1969 Dec; 74(6):461-75. PubMed ID: 5406384
    [No Abstract]   [Full Text] [Related]  

  • 22. [Our experience with exchange transfusion in hemolytic disease of the newborn].
    Racheva B; Marinova N
    Akush Ginekol (Sofiia); 1965; 4(5):471-6. PubMed ID: 5894278
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood chemical parameters in newborn infants with fetal erythroblastosis during exchange transfusion].
    Macchia A; Gori A; De Punzio C; Baisi F
    Minerva Ginecol; 1981 Jun; 33(6):548-53. PubMed ID: 7197006
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical follow-up studies on late prognosis of Rh-related hemolytic disease of the newborn. VII. Indications for exchange transfusion in Rh-incompatibility].
    Schneeweiss B
    Padiatr Grenzgeb; 1970; 9(3):208-17. PubMed ID: 4997628
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems of exchange transfusion involving newborn infants].
    Shimada N
    Sanfujinka No Jissai; 1970 Jun; 19(6):562-7. PubMed ID: 5468468
    [No Abstract]   [Full Text] [Related]  

  • 26. [Our experience with exchange transfusion of newborn infants with hemolytic disease].
    Sakakushev E; Tashev V; Ataiasov A
    Akush Ginekol (Sofiia); 1969; 8(1):75-80. PubMed ID: 5408742
    [No Abstract]   [Full Text] [Related]  

  • 27. [Results of exchange transfusion in hemolytic disease of newborn infants].
    Novachev D; Ilieva V
    Akush Ginekol (Sofiia); 1966; 5(4):274-6. PubMed ID: 6012141
    [No Abstract]   [Full Text] [Related]  

  • 28. [Intraperitoneal transfusion of the fetus in the treatment of rhesus isoimmunization. Apropos of 3 cases].
    Hartemann J; Streiff F; Landes P; Genetet B; Brunel G; Vert P
    Gynecol Obstet (Paris); 1968; 67(4):411-24. PubMed ID: 5701975
    [No Abstract]   [Full Text] [Related]  

  • 29. [Early exchange transfusion - important factor in the treatment of hemolytic disease of the newborn].
    Stadler M; Munteanu I
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1975 Aug; 23(8):25-7. PubMed ID: 817497
    [No Abstract]   [Full Text] [Related]  

  • 30. [Transfusion treatment in hemolytic disease of the newborn].
    Peyretti F
    Pathologica; 1972; 64(933):239-41. PubMed ID: 4677645
    [No Abstract]   [Full Text] [Related]  

  • 31. [100 fetal blood transfusions].
    Santarelli J; Duval C; Baudelot J
    Rev Fr Gynecol Obstet; 1972; 67(8):451-64. PubMed ID: 4645501
    [No Abstract]   [Full Text] [Related]  

  • 32. [The neuropsychological development of children with hemolytic disease of the newborn].
    Benko J; Szabová I
    Cesk Gynekol; 1969 Oct; 34(8):493-5. PubMed ID: 4187912
    [No Abstract]   [Full Text] [Related]  

  • 33. Hyperbilirubinemia secondary to hemolysis of intrauterine intraperitoneal blood transfusion.
    Rajagopalan I; Katz BZ
    Clin Pediatr (Phila); 1984 Sep; 23(9):511-2. PubMed ID: 6467786
    [No Abstract]   [Full Text] [Related]  

  • 34. [Long term psychological observation of children treated with exsanguination transfusion for hemolytic disease of the newborn. II. Intellectual abilities and speech defects].
    Trávníková M
    Cesk Pediatr; 1969 Dec; 24(12):1073-9. PubMed ID: 4188574
    [No Abstract]   [Full Text] [Related]  

  • 35. [ABO hemolytic disease of the newborn. Treatment by exsanguination transfusion].
    Lange MM
    Pathologica; 1972; 64(935):315-24. PubMed ID: 4677646
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hemolytic disease of the newborn caused by rare incompatibility in the Rhesus system].
    Perrimond H; Battaglini P; Melis C; Sebag F; Chauvin C; Orsini A
    Mars Med; 1972; 109(4):275-8. PubMed ID: 5070402
    [No Abstract]   [Full Text] [Related]  

  • 37. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 38. [Factors influencing the effectivity of exchange transfusion in the newborn].
    Jerzykowska-Kuleszyna K
    Pediatr Pol; 1967 Sep; 42(9):1133-8. PubMed ID: 6070575
    [No Abstract]   [Full Text] [Related]  

  • 39. Letter: Hemolytic disease of the newborn.
    Bowman JW
    Can Med Assoc J; 1975 Jan; 112(2):134. PubMed ID: 1167480
    [No Abstract]   [Full Text] [Related]  

  • 40. [Transfusion-induced acid load caused by erythrocyte concentrates in the newborn].
    Abel M; Fürste HO; Pringsheim W; Sievers JW; Otto J
    Infusionsther Klin Ernahr; 1984 Oct; 11(5):267-9. PubMed ID: 6511085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.